Phibro Animal Health (NASDAQ:PAHC) Share Price Crosses Below Two Hundred Day Moving Average – Here’s Why

Posted by Francis Steltz on Aug 15th, 2026

Phibro Animal Health Corporation (NASDAQ:PAHC – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $42.82 and traded as low as $33.83. Phibro Animal Health shares last traded at $34.06, with a volume of 128,887 shares changing hands.

Analyst Ratings Changes

Several research firms have recently commented on PAHC. Citigroup decreased their target price on shares of Phibro Animal Health from $62.00 to $44.00 and set a “neutral” rating for the company in a research report on Thursday, May 14th. Weiss Ratings downgraded Phibro Animal Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, June 15th. Wall Street Zen lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Finally, Zacks Research downgraded Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research note on Thursday, May 21st. One analyst has rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $42.50.

Check Out Our Latest Stock Analysis on PAHC

Phibro Animal Health Stock Performance

The company’s 50-day simple moving average is $33.34 and its 200 day simple moving average is $42.76. The stock has a market cap of $1.39 billion, a P/E ratio of 14.75, a PEG ratio of 0.48 and a beta of 0.46. The company has a current ratio of 3.17, a quick ratio of 1.26 and a debt-to-equity ratio of 1.97.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Wednesday, September 2nd will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Wednesday, September 2nd. Phibro Animal Health’s dividend payout ratio (DPR) is 20.60%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of PAHC. Ranger Investment Management L.P. purchased a new stake in shares of Phibro Animal Health during the 2nd quarter valued at $9,182,000. Globeflex Capital L P bought a new stake in shares of Phibro Animal Health during the 2nd quarter worth $5,942,000. Bank of America Corp DE boosted its holdings in shares of Phibro Animal Health by 22.6% in the 1st quarter. Bank of America Corp DE now owns 78,957 shares of the company’s stock worth $4,367,000 after buying an additional 14,536 shares during the last quarter. Systematic Alpha Investments LLC purchased a new position in shares of Phibro Animal Health in the 1st quarter worth about $293,000. Finally, Amundi bought a new position in Phibro Animal Health during the first quarter valued at about $539,000. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

(Get Free Report)

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.